Copyright
©The Author(s) 2025.
World J Hepatol. Dec 27, 2025; 17(12): 113639
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.113639
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.113639
Figure 1 Comparison chart of the steatotic liver disease group and the non-steatotic liver disease group.
A: Distribution of body mass index categories; B: Distribution of genotypes; C: Liver disease severity based on elastography; D: Distribution of aspartate aminotransferase to platelet ratio index categories; E: Distribution of fibrosis-4 index categories; F: Effectiveness of direct-acting antiviral therapy. SLD: Steatotic liver disease; F: Fibrosis; ITT: Intention-to-treat; PP: Per-protocol.
- Citation: Janczura J, Brzdęk M, Flisiak R, Dobrowolska K, Brzdęk K, Rzymski P, Zarębska-Michaluk D. Steatotic liver disease in patients with chronic hepatitis C. World J Hepatol 2025; 17(12): 113639
- URL: https://www.wjgnet.com/1948-5182/full/v17/i12/113639.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i12.113639
